StreetInsider.com  Oct 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Generex+Biotech+%28GNBT%29+Unit+Publishes+White+Paper+Promoting+Ii-Key+in+Ebola+Vaccine+Development/9927113.html for the full story.
Penny Stock Classroom  Jul 8  Comment 
Stocks fell today as the economy added only 18,000 jobs in June, well below the 125,000 jobs analysts’ had expected. Job gains in May were also revised down to 25,000 from the initial estimate of 54,000. Employment has come to a near stand still...
StreetInsider.com  Jun 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Generex+Biotechnology+%28GNBT%29+Provides+Update+on+Generex+Oral-lyn+Clinical+%26+Regulatory+Program/6585559.html for the full story.
StreetInsider.com  Feb 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Generex+%28GNBT%29+Unit+Receives+U.S.+Patent+Notice+of+Allowance+for+AE37+Cancer+Vaccine/6256367.html for the full story.
StreetInsider.com  Jan 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Generex+%28GNBT%29+and+RXi+Pharma+%28RXII%29+Announce+Positive+RNAi+Development+Data/6201318.html for the full story.
StreetInsider.com  Oct 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Generex+Biotechnology+%28GNBT%29+Removes+From+NASDAQ%3B+Begins+Trading+on+OTC+Market/6040458.html for the full story.
StreetInsider.com  Oct 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Generex+Biotech+%28GNBT%29+to+Be+Delisted+from+Nasdaq%3B+to+Continue+Production+Development+Initiatives/6040426.html for the full story.
Benzinga  Oct 18  Comment 
Generex Biotechnology Corporation (Nasdaq: GNBT) announced today that Dr. Joseph Rubinfeld, an independent scientific advisor to the Company and a member of the Company's Scientific Advisory Board, issued the following statement in respect of the...
Benzinga  Oct 11  Comment 
Generex Biotechnology Corporation (Nasdaq: GNBT) today announced that it plans to initiate a rights offering of common stock and warrants to its existing stockholders in the event that the stockholders approve a reverse stock split at the...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki